Clinical Trials Directory

Trials / Unknown

UnknownNCT05053204

Influence Factors and Cognitive Characteristics in Unipolar and Bipolar Depression:Based on the THINC-it Tool

Based on the THINC-it Tool to Explore the Characteristics and Related Factors of Cognitive Impairment in the Acute Stage of Unipolar and Bipolar Depression

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Cognitive impairment is the core symptom of unipolar and bipolar depression, which seriously affects the prognosis of the disease and the rehabilitation of social function. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. In this study,the THINC-it tool was used to study the characteristics of cognitive impairment in unipolar and bipolar depression by longitudinal follow-up, which provides a theoretical basis for the differential diagnosis of unipolar and bipolar depression. Early identification and intervention of risk factors can improve the prognosis of the disease.

Detailed description

there is some cognitive impairment in patients with unipolar and bipolar depression. There is no unified conclusion in the field and severity of cognitive impairment, and the cause of cognitive impairment is unknown, which may be related to many factors. The THINC-it is a simple, fast and free cognitive assessment tool for cognitive impairment screening of unipolar and bipolar depression. This study includes three steps. 1. baseline: demographic data, theTHINC-it tool , clinical scales(HAMD-17,HAMA、YMRS、PSQI) evaluation and Laboratory examination(blood glucose, blood lipids, BMI) 2. follow-up (4 week): Clinical scales and THINC-it tool were evaluated in unipolar and bipolar depression. 3. follow-up (12 weeks): all patients with bipolar depression were evaluated by clinical scales, THINC-it test.

Conditions

Interventions

TypeNameDescription
OTHER

Timeline

Start date
2021-05-15
Primary completion
2022-10-30
Completion
2023-06-30
First posted
2021-09-22
Last updated
2022-09-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05053204. Inclusion in this directory is not an endorsement.